ANBIO BIOTECHNOLOGY
NNNN·G0367B105·US·Common Stock·Healthcare - Medical Instruments & Supplies
NNNN (ANBIO BIOTECHNOLOGY) is held by 8 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($366,550), BANK OF AMERICA CORP /DE/ ($183,974), BNP PARIBAS FINANCIAL MARKETS ($161,778). Net institutional sentiment: Mixed.
8
Holders
$982,257
Total Value
67% (9)
Consensus
6 buying - 3 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for NNNN.
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer